{"id":9750,"date":"2021-05-11T08:01:30","date_gmt":"2021-05-11T06:01:30","guid":{"rendered":"https:\/\/ggba.swiss\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/"},"modified":"2023-07-04T13:43:36","modified_gmt":"2023-07-04T11:43:36","slug":"specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/","title":{"rendered":"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions"},"content":{"rendered":"

Install\u00e9e \u00e0 l’EPFL Innovation Park<\/a> \u00e0 Lausanne, Oculis<\/a> d\u00e9tient un important portefeuille de produits en d\u00e9veloppement, notamment des traitements topiques (gouttes ophtalmiques) en phase avanc\u00e9e de d\u00e9veloppement, qui sont non invasifs et repr\u00e9sentent une avanc\u00e9e technique in\u00e9dite pour les patients souffrant d’\u0153d\u00e8mes de la r\u00e9tine et de maladies de la face avant des yeux.<\/p>\n

En outre, les capacit\u00e9s de recherche et d’innovation d’Oculis en mati\u00e8re de formulation permettent le d\u00e9veloppement d’un pipeline de m\u00e9dicaments topiques ciblant les maladies oculaires mena\u00e7ant la vue et affectant les segments ant\u00e9rieur et post\u00e9rieur de l’\u0153il.<\/p>\n

La soci\u00e9t\u00e9 vaudoise a boucl\u00e9 un tour de table de s\u00e9rie C de $57 millions, men\u00e9 conjointement par les nouveaux investisseurs BVCF Management<\/a> et Hyfinity Investments<\/a>, VI Partners<\/a> et Wille AG<\/a>, qui rejoignent les investisseurs existants de la soci\u00e9t\u00e9, Bay City Capital<\/a>, Brunnur Ventures<\/a> et EarlyBird<\/a>.<\/p>\n

Les fonds obtenus gr\u00e2ce \u00e0 ce financement permettront d’acc\u00e9l\u00e9rer la strat\u00e9gie d’Oculis. Les \u00e9tapes cibl\u00e9es couvrent le d\u00e9veloppement de nouvelles th\u00e9rapies topiques pour les maladies ophtalmiques ciblant la r\u00e9tine et le segment ant\u00e9rieur et pr\u00e9sentant des besoins consid\u00e9rables et non satisfaits.<\/p>\n

Zhi Yang, Managing Partner chez BVCF Management, a d\u00e9clar\u00e9 : \u00ab\u00a0la technologie innovante d’Oculis et son approche topique transformatrice pour traiter les maladies mena\u00e7ant la vue ont le potentiel d’\u00e9tendre consid\u00e9rablement la port\u00e9e de ces th\u00e9rapies \u00e0 un plus grand nombre de patients, am\u00e9liorant ainsi l’accessibilit\u00e9 et la conformit\u00e9 et, \u00e0 terme, les r\u00e9sultats cliniques. Ce potentiel in\u00e9gal\u00e9, la force de l’\u00e9quipe internationale d’Oculis et les besoins m\u00e9dicaux non satisfaits croissants sur les principaux march\u00e9s cl\u00e9s dans le monde sont les facteurs cl\u00e9s derri\u00e8re la d\u00e9cision de BVCF et de nos coll\u00e8gues investisseurs qui ont particip\u00e9 \u00e0 ce nouveau tour de financement.\u00a0\u00bb<\/p>\n","protected":false},"excerpt":{"rendered":"

Oculis, soci\u00e9t\u00e9 biopharmaceutique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de traitements ophtalmiques innovants, a annonc\u00e9 la cl\u00f4ture d’un tour de financement de s\u00e9rie C sursouscrit de $ 57 millions.<\/p>\n","protected":false},"author":3,"featured_media":9751,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1022,1041,1068],"class_list":["post-9750","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr","tag-financing-fr","tag-personalized-medicine-fr"],"acf":[],"yoast_head":"\nLe sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"Oculis, soci\u00e9t\u00e9 biopharmaceutique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de traitements ophtalmiques innovants, a annonc\u00e9 la cl\u00f4ture d'un tour de financement de s\u00e9rie C sursouscrit de $ 57 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-11T06:01:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"381\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions\",\"datePublished\":\"2021-05-11T06:01:30+00:00\",\"dateModified\":\"2023-07-04T11:43:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/\"},\"wordCount\":342,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg\",\"keywords\":[\"Biotech\",\"Financing\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/\",\"name\":\"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg\",\"datePublished\":\"2021-05-11T06:01:30+00:00\",\"dateModified\":\"2023-07-04T11:43:36+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg\",\"width\":630,\"height\":381},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/","og_locale":"fr_FR","og_type":"article","og_title":"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions - Greater Geneva Bern area","og_description":"Oculis, soci\u00e9t\u00e9 biopharmaceutique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de traitements ophtalmiques innovants, a annonc\u00e9 la cl\u00f4ture d'un tour de financement de s\u00e9rie C sursouscrit de $ 57 millions.","og_url":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2021-05-11T06:01:30+00:00","article_modified_time":"2023-07-04T11:43:36+00:00","og_image":[{"width":630,"height":381,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions","datePublished":"2021-05-11T06:01:30+00:00","dateModified":"2023-07-04T11:43:36+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/"},"wordCount":342,"image":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg","keywords":["Biotech","Financing","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/","url":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/","name":"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg","datePublished":"2021-05-11T06:01:30+00:00","dateModified":"2023-07-04T11:43:36+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-3.jpg","width":630,"height":381},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/specialiste-vaudois-traitements-ophtalmiques-oculis-leve-57-millions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Le sp\u00e9cialiste vaudois des traitements ophtalmiques Oculis l\u00e8ve $ 57 millions"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9750","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=9750"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9750\/revisions"}],"predecessor-version":[{"id":17926,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9750\/revisions\/17926"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/9751"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=9750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=9750"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=9750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}